-+ 0.00%
-+ 0.00%
-+ 0.00%

enGene Q1 net loss attributable to common shareholders rises 21% to USD 29.75 million on 17% higher operating expenses of USD 31.19 million

Reuters·03/09/2026 11:01:04

Please log in to view news